Dyne Therapeutics vs Viking Therapeutics: 2026 Buy Guide
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Discover why indices rise or fall, examining earnings, macro data, and policy factors that shape broad market direction.
21,369 articlesTwo clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
GCC debt markets have rallied since the ceasefire, lifting bond and sukuk prices while issuers return to the market. ...
Opendoor and Offerpad led a narrow iBuyer rally with midday gains of about 7% and 6%, respectively. The move comes as...
Facing a potential funding gap for Social Security, seniors can take concrete steps today. Learn three actionable mea...
A sharp month-long sell-off pushed AeroVironment shares down by more than 20%. This article breaks down the catalysts...
Micron's memory leadership and AI-ready HBM4 shipments clash with Intel's restructuring effort and foundry bets. As A...
XRP ETFs posted their first weekly red bar after months of inflows, while Bitcoin and Ethereum ETFs logged solid gain...
Evercore ISI launches SpaceX coverage with an Outperform rating and a $230 target, fueling a new wall street spacex b...
A single family moment can reveal big money lessons. This article turns a pop culture moment into actionable steps fo...
Gasoline prices fell in January, easing inflation pressure and giving households room to save. The trend could bolste...
A policy debate is heating up around whether large investors should be restricted from buying single-family rentals. ...
Berkshire Hathaway cut a large portion of its Amazon position and deployed capital into The New York Times, a calcula...